Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | CASP6 | P55212 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SENP2 | Q9HC62 | 3/20 | 0.48 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.48 |
| ▸ | SUMO1 | P63165 | 2/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.48 |
| ▸ | TIMP3 | P35625 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | NT5E | P21589 | 3/20 | 0.41 |
| ▸ | NSD2 | O96028 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL229199 | 1.00 | AURKA (0.53) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL26983155 | 0.98 | AURKA (0.51) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL8379561 | 0.98 | AURKA (0.51) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL11568447 | 0.88 | ALDH1A1 (0.57) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL156092 | 0.87 | AURKA (0.62) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL10539390 | 0.87 | AURKA (0.62) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL29706553 | 0.87 | AURKA (0.62) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL29642783 | 0.85 | TIMP3 (0.51) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL20577653 | 0.85 | TIMP3 (0.51) | AURKAAURKBHSD17B10ALDH1A1CASP6 | |
| SCHEMBL445795 | 0.85 | AURKA (0.60) | AURKAAURKBHSD17B10ALDH1A1CASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954991-A | High oxygen permeability ionomer with large steric hindrance group, and preparation method and application thereof | 武汉大学 | 2025-05-09 | — | — | CN | claimed |
| CN-118045574-A | S-triazine modified straw-based dye adsorbent and preparation method and application thereof | 青岛理工大学 | 2024-05-17 | — | — | CN | claimed |
| US-20250333472-A1 | Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto | GEORGE MASON RES FOUNDATION INC (US) | 2025-10-30 | — | — | US | disclosed |
| CN-119954991-A | High oxygen permeability ionomer with large steric hindrance group, and preparation method and application thereof | 武汉大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-118045574-A | S-triazine modified straw-based dye adsorbent and preparation method and application thereof | 青岛理工大学 | 2024-05-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333472-A1 | Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto | SNRPE, SSBP1, RPA1 | AURKA 3644/4885AURKB 1915/4885HSD17B10 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.